Tonix CEO’s Insider Buying Signals Confidence in TONMYA Expansion
Tonix Pharmaceuticals insider buying signals CEO confidence amid tough market: coverage expands for TONMYA®, but cash flow remains flat and earnings negative. Read the analysis.
- TONIX PHARMACEUTICALS HOLDIN
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
5 minutes to read